Kleo Pharmaceuticals Presents Preclinical Data Supporting Development of its CD38-ARM™, a Novel Immuno-therapeutic, at American Society of Hematology (ASH) Annual Meeting
Date & Time: Saturday, December 7, 2019, 5:30 p.m. – 7:30 p.m.
Session: 652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster
Kleo Pharmaceuticals Presents Preclinical Data Supporting Development of its CD38-ARM™, a Novel Immuno-therapeutic, at American Society of Hematology (ASH) Annual Meeting
Date & Time: Saturday, December 7, 2019, 5:30 p.m. – 7:30 p.m.
Session: 652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster